Paper Details

Paper Title

Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung Organoids.

Paper Journal Title

bioRxiv

Paper Citation Count

Paper Publication Year

2020

Bio Mention

-CoV, -derived lung cells, ACE2, COVID-19, COVID-19 disease, SARS, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 virus, aveolar type II cells, hPSC, hPSC-derived Lung Organoids, hPSC-derived lung cells, hPSC-derived lung organoids, hPSCs, human, human disease-relevant cells, human pluripotent stem cells, imatinib, mycophenolic acid, pulmonary infections, type I/III interferon

Mesh Descriptor

Paper Details

Column Actions

Datasets